nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—CYP2D6—Parkinson's disease	0.526	0.583	CbGaD
Amsacrine—ABCB1—Parkinson's disease	0.375	0.417	CbGaD
Amsacrine—NCOA3—hindbrain—Parkinson's disease	0.00644	0.152	CbGeAlD
Amsacrine—NCOA3—brainstem—Parkinson's disease	0.00369	0.0869	CbGeAlD
Amsacrine—NCOA3—Androgen receptor signaling pathway—PARK7—Parkinson's disease	0.00276	0.0487	CbGpPWpGaD
Amsacrine—NCOA3—medulla oblongata—Parkinson's disease	0.00257	0.0606	CbGeAlD
Amsacrine—NCOA3—midbrain—Parkinson's disease	0.00235	0.0554	CbGeAlD
Amsacrine—NCOA3—spinal cord—Parkinson's disease	0.0023	0.054	CbGeAlD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—ATXN2—Parkinson's disease	0.00226	0.0398	CbGpPWpGaD
Amsacrine—NCOA3—head—Parkinson's disease	0.00204	0.048	CbGeAlD
Amsacrine—NCOA3—nervous system—Parkinson's disease	0.00193	0.0455	CbGeAlD
Amsacrine—KCNH2—Potassium Channels—HCN3—Parkinson's disease	0.00187	0.033	CbGpPWpGaD
Amsacrine—NCOA3—central nervous system—Parkinson's disease	0.00186	0.0438	CbGeAlD
Amsacrine—NCOA3—cerebellum—Parkinson's disease	0.00182	0.0428	CbGeAlD
Amsacrine—NCOA3—FOXA1 transcription factor network—SOD1—Parkinson's disease	0.00172	0.0304	CbGpPWpGaD
Amsacrine—NCOA3—brain—Parkinson's disease	0.00148	0.0348	CbGeAlD
Amsacrine—CYP2D6—hindbrain—Parkinson's disease	0.00129	0.0304	CbGeAlD
Amsacrine—NCOA3—Validated nuclear estrogen receptor alpha network—SOD1—Parkinson's disease	0.00128	0.0225	CbGpPWpGaD
Amsacrine—ABCB1—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.00126	0.0222	CbGpPWpGaD
Amsacrine—KCNH2—Potassium Channels—KCNJ4—Parkinson's disease	0.0012	0.0213	CbGpPWpGaD
Amsacrine—KCNH2—forebrain—Parkinson's disease	0.00117	0.0276	CbGeAlD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.00116	0.0204	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—NRTN—Parkinson's disease	0.00109	0.0192	CbGpPWpGaD
Amsacrine—NCOA3—FOXA1 transcription factor network—INS—Parkinson's disease	0.00109	0.0191	CbGpPWpGaD
Amsacrine—NCOA3—PPARA activates gene expression—CTGF—Parkinson's disease	0.00105	0.0185	CbGpPWpGaD
Amsacrine—NCOA3—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—Parkinson's disease	0.00103	0.0181	CbGpPWpGaD
Amsacrine—NCOA3—Retinoic acid receptors-mediated signaling—MAPK8—Parkinson's disease	0.00101	0.0178	CbGpPWpGaD
Amsacrine—KCNH2—cardiovascular system—Parkinson's disease	0.000991	0.0233	CbGeAlD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.000878	0.0155	CbGpPWpGaD
Amsacrine—KCNH2—medulla oblongata—Parkinson's disease	0.000846	0.0199	CbGeAlD
Amsacrine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.000846	0.0149	CbGpPWpGaD
Amsacrine—CYP2D6—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.00084	0.0148	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—HCN3—Parkinson's disease	0.000816	0.0144	CbGpPWpGaD
Amsacrine—KCNH2—midbrain—Parkinson's disease	0.000774	0.0182	CbGeAlD
Amsacrine—KCNH2—spinal cord—Parkinson's disease	0.000755	0.0178	CbGeAlD
Amsacrine—CYP2D6—brainstem—Parkinson's disease	0.00074	0.0174	CbGeAlD
Amsacrine—CYP2D6—forebrain—Parkinson's disease	0.000714	0.0168	CbGeAlD
Amsacrine—NCOA3—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—Parkinson's disease	0.000708	0.0125	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—DLG1—Parkinson's disease	0.000679	0.012	CbGpPWpGaD
Amsacrine—KCNH2—head—Parkinson's disease	0.000671	0.0158	CbGeAlD
Amsacrine—KCNH2—nervous system—Parkinson's disease	0.000636	0.015	CbGeAlD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000626	0.011	CbGpPWpGaD
Amsacrine—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000622	0.011	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—ABL1—Parkinson's disease	0.000612	0.0108	CbGpPWpGaD
Amsacrine—KCNH2—central nervous system—Parkinson's disease	0.000612	0.0144	CbGeAlD
Amsacrine—KCNH2—cerebellum—Parkinson's disease	0.000598	0.0141	CbGeAlD
Amsacrine—ABCB1—embryo—Parkinson's disease	0.000581	0.0137	CbGeAlD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—ABL1—Parkinson's disease	0.000579	0.0102	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.000548	0.00966	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—GDNF—Parkinson's disease	0.000531	0.00937	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—KCNJ4—Parkinson's disease	0.000526	0.00928	CbGpPWpGaD
Amsacrine—CYP2D6—Xenobiotics—CYP2E1—Parkinson's disease	0.000521	0.00919	CbGpPWpGaD
Amsacrine—ABCB1—forebrain—Parkinson's disease	0.000514	0.0121	CbGeAlD
Amsacrine—CYP2D6—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000501	0.00884	CbGpPWpGaD
Amsacrine—KCNH2—brain—Parkinson's disease	0.000486	0.0114	CbGeAlD
Amsacrine—TOP2A—Circadian rythm related genes—DDC—Parkinson's disease	0.000463	0.00817	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—DLG1—Parkinson's disease	0.000454	0.00801	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.000444	0.00783	CbGpPWpGaD
Amsacrine—ABCB1—cardiovascular system—Parkinson's disease	0.000435	0.0102	CbGeAlD
Amsacrine—TOP2A—Retinoblastoma (RB) in Cancer—ABL1—Parkinson's disease	0.000417	0.00736	CbGpPWpGaD
Amsacrine—CYP2D6—head—Parkinson's disease	0.000409	0.00962	CbGeAlD
Amsacrine—ABCB1—Allograft Rejection—LRRK2—Parkinson's disease	0.000391	0.0069	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000391	0.00689	CbGpPWpGaD
Amsacrine—CYP2D6—nervous system—Parkinson's disease	0.000388	0.00912	CbGeAlD
Amsacrine—NCOA3—Transcriptional regulation of white adipocyte differentiation—TNF—Parkinson's disease	0.000376	0.00663	CbGpPWpGaD
Amsacrine—CYP2D6—central nervous system—Parkinson's disease	0.000373	0.00878	CbGeAlD
Amsacrine—ABCB1—medulla oblongata—Parkinson's disease	0.000371	0.00873	CbGeAlD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—Parkinson's disease	0.00037	0.00653	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.000369	0.0065	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.000368	0.0065	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—MCCC1—Parkinson's disease	0.000368	0.00649	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ND3—Parkinson's disease	0.000368	0.00649	CbGpPWpGaD
Amsacrine—CYP2D6—cerebellum—Parkinson's disease	0.000365	0.00859	CbGeAlD
Amsacrine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000361	0.00638	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—GRIK1—Parkinson's disease	0.000355	0.00627	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.000355	0.00626	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.000349	0.00616	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—OMD—Parkinson's disease	0.000346	0.0061	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—TALDO1—Parkinson's disease	0.000346	0.0061	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—ADORA2A—Parkinson's disease	0.000346	0.0061	CbGpPWpGaD
Amsacrine—ABCB1—midbrain—Parkinson's disease	0.000339	0.00798	CbGeAlD
Amsacrine—ABCB1—Allograft Rejection—GDNF—Parkinson's disease	0.000332	0.00586	CbGpPWpGaD
Amsacrine—ABCB1—spinal cord—Parkinson's disease	0.000331	0.00779	CbGeAlD
Amsacrine—NCOA3—Metabolism—NDUFB11—Parkinson's disease	0.000328	0.00578	CbGpPWpGaD
Amsacrine—CYP2D6—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000318	0.00562	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—HSPA8—Parkinson's disease	0.000317	0.0056	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GCH1—Parkinson's disease	0.000313	0.00552	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—VIM—Parkinson's disease	0.000312	0.00551	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.000305	0.00539	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—GRIK2—Parkinson's disease	0.000302	0.00533	CbGpPWpGaD
Amsacrine—NCOA3—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.000301	0.00532	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—DLG4—Parkinson's disease	0.000298	0.00525	CbGpPWpGaD
Amsacrine—CYP2D6—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000297	0.00523	CbGpPWpGaD
Amsacrine—CYP2D6—brain—Parkinson's disease	0.000296	0.00697	CbGeAlD
Amsacrine—ABCB1—head—Parkinson's disease	0.000294	0.00692	CbGeAlD
Amsacrine—KCNH2—Neuronal System—SLC18A2—Parkinson's disease	0.000292	0.00516	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—GRIN2B—Parkinson's disease	0.000291	0.00513	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—CP—Parkinson's disease	0.000291	0.00513	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—DRD1—Parkinson's disease	0.00029	0.00511	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000282	0.00498	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—DRD3—Parkinson's disease	0.000281	0.00495	CbGpPWpGaD
Amsacrine—ABCB1—nervous system—Parkinson's disease	0.000279	0.00656	CbGeAlD
Amsacrine—NCOA3—Metabolism—GBA—Parkinson's disease	0.000279	0.00492	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—FBP1—Parkinson's disease	0.000279	0.00492	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—DBH—Parkinson's disease	0.000279	0.00492	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—HLA-DRA—Parkinson's disease	0.000276	0.00488	CbGpPWpGaD
Amsacrine—ABCB1—central nervous system—Parkinson's disease	0.000269	0.00632	CbGeAlD
Amsacrine—ABCB1—cerebellum—Parkinson's disease	0.000263	0.00618	CbGeAlD
Amsacrine—NCOA3—EGF/EGFR Signaling Pathway—MAPK8—Parkinson's disease	0.000262	0.00462	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—TH—Parkinson's disease	0.000258	0.00456	CbGpPWpGaD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000258	0.00455	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000258	0.00455	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—HTR7—Parkinson's disease	0.000254	0.00448	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—DRD2—Parkinson's disease	0.000254	0.00448	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000249	0.00439	CbGpPWpGaD
Amsacrine—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000241	0.00426	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—ABL1—Parkinson's disease	0.000237	0.00419	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—CHRNA4—Parkinson's disease	0.000231	0.00408	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000222	0.00392	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000221	0.0039	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—DCTN1—Parkinson's disease	0.00022	0.00389	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.000219	0.00387	CbGpPWpGaD
Amsacrine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—Parkinson's disease	0.000217	0.00384	CbGpPWpGaD
Amsacrine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—Parkinson's disease	0.000217	0.00382	CbGpPWpGaD
Amsacrine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000216	0.00382	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.000215	0.0038	CbGpPWpGaD
Amsacrine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000213	0.00377	CbGpPWpGaD
Amsacrine—ABCB1—brain—Parkinson's disease	0.000213	0.00502	CbGeAlD
Amsacrine—KCNH2—Neuronal System—HSPA8—Parkinson's disease	0.000212	0.00374	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00021	0.00371	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—DDC—Parkinson's disease	0.000205	0.00361	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—DLG4—Parkinson's disease	0.000199	0.00351	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—DCTN1—Parkinson's disease	0.000197	0.00348	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—GRIN2B—Parkinson's disease	0.000195	0.00343	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000194	0.00343	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GSTA4—Parkinson's disease	0.000193	0.00341	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—SLC6A3—Parkinson's disease	0.000192	0.00338	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000191	0.00337	CbGpPWpGaD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000175	0.00309	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PLA2G6—Parkinson's disease	0.000174	0.00307	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—Parkinson's disease	0.000173	0.00305	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—MAOB—Parkinson's disease	0.000172	0.00304	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000164	0.00289	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—COMT—Parkinson's disease	0.000163	0.00288	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—EDN1—Parkinson's disease	0.000163	0.00288	CbGpPWpGaD
Amsacrine—KCNH2—Neuronal System—MAOA—Parkinson's disease	0.000162	0.00286	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—INS—Parkinson's disease	0.000157	0.00277	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	0.000154	0.00271	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000152	0.00267	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.000146	0.00258	CbGpPWpGaD
Amsacrine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000144	0.00254	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.000137	0.00242	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—FASLG—Parkinson's disease	0.00013	0.00229	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYP2D6—Parkinson's disease	0.000128	0.00226	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CTGF—Parkinson's disease	0.000126	0.00222	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000125	0.0022	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000124	0.00219	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.000121	0.00214	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYP2E1—Parkinson's disease	0.000117	0.00207	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—NQO1—Parkinson's disease	0.000116	0.00204	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—TH—Parkinson's disease	0.000114	0.00201	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—CYCS—Parkinson's disease	0.00011	0.00193	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000109	0.00193	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000101	0.00178	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000101	0.00178	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000101	0.00177	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—COMT—Parkinson's disease	9.7e-05	0.00171	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—MAPK8—Parkinson's disease	9.66e-05	0.0017	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GSTP1—Parkinson's disease	9.65e-05	0.0017	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—MAOA—Parkinson's disease	9.63e-05	0.0017	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—HMOX1—Parkinson's disease	9.52e-05	0.00168	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	9.31e-05	0.00164	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	9.18e-05	0.00162	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—ABCB1—Parkinson's disease	9.14e-05	0.00161	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—TNF—Parkinson's disease	9.04e-05	0.00159	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GSTM1—Parkinson's disease	8.87e-05	0.00157	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—GPX1—Parkinson's disease	8.5e-05	0.0015	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—TNF—Parkinson's disease	8.49e-05	0.0015	CbGpPWpGaD
Amsacrine—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	7.96e-05	0.0014	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—MTHFR—Parkinson's disease	7.84e-05	0.00138	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—COMT—Parkinson's disease	7.72e-05	0.00136	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	7.68e-05	0.00136	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	7.66e-05	0.00135	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	7.61e-05	0.00134	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	7.57e-05	0.00134	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	7.32e-05	0.00129	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—IL1B—Parkinson's disease	7.32e-05	0.00129	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—CASP3—Parkinson's disease	7.3e-05	0.00129	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—APOE—Parkinson's disease	7.3e-05	0.00129	CbGpPWpGaD
Amsacrine—KCNH2—SIDS Susceptibility Pathways—IL6—Parkinson's disease	7.29e-05	0.00129	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	7.21e-05	0.00127	CbGpPWpGaD
Amsacrine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	7.06e-05	0.00125	CbGpPWpGaD
Amsacrine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	6.96e-05	0.00123	CbGpPWpGaD
Amsacrine—NCOA3—Developmental Biology—IL6—Parkinson's disease	6.85e-05	0.00121	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	6.4e-05	0.00113	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—INS—Parkinson's disease	6.24e-05	0.0011	CbGpPWpGaD
Amsacrine—TOP2A—Circadian rythm related genes—IL6—Parkinson's disease	6.17e-05	0.00109	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.36e-05	0.000946	CbGpPWpGaD
Amsacrine—ABCB1—Allograft Rejection—TNF—Parkinson's disease	5.31e-05	0.000937	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MCCC1—Parkinson's disease	5.31e-05	0.000937	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ND3—Parkinson's disease	5.31e-05	0.000937	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ND3—Parkinson's disease	5e-05	0.000883	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	5e-05	0.000883	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TALDO1—Parkinson's disease	4.99e-05	0.000881	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—OMD—Parkinson's disease	4.99e-05	0.000881	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	4.93e-05	0.000871	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NDUFB11—Parkinson's disease	4.73e-05	0.000835	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—OMD—Parkinson's disease	4.7e-05	0.00083	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	4.7e-05	0.00083	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GCH1—Parkinson's disease	4.51e-05	0.000797	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.46e-05	0.000787	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GCH1—Parkinson's disease	4.25e-05	0.000751	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—FBP1—Parkinson's disease	4.02e-05	0.00071	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—DBH—Parkinson's disease	4.02e-05	0.00071	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GBA—Parkinson's disease	4.02e-05	0.00071	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—DBH—Parkinson's disease	3.79e-05	0.000669	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GBA—Parkinson's disease	3.79e-05	0.000669	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—FBP1—Parkinson's disease	3.79e-05	0.000669	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	3.6e-05	0.000636	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.52e-05	0.00062	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.38e-05	0.000596	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	3.31e-05	0.000584	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—DDC—Parkinson's disease	2.95e-05	0.000521	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.93e-05	0.000518	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTA4—Parkinson's disease	2.79e-05	0.000492	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—DDC—Parkinson's disease	2.78e-05	0.000491	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.63e-05	0.000464	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.62e-05	0.000462	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PLA2G6—Parkinson's disease	2.51e-05	0.000443	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MAOB—Parkinson's disease	2.49e-05	0.000439	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.37e-05	0.000418	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.34e-05	0.000413	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.85e-05	0.000326	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CTGF—Parkinson's disease	1.81e-05	0.00032	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.71e-05	0.000302	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.69e-05	0.000298	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NQO1—Parkinson's disease	1.67e-05	0.000295	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TH—Parkinson's disease	1.65e-05	0.000291	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.59e-05	0.000281	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYCS—Parkinson's disease	1.58e-05	0.000279	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.57e-05	0.000278	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TH—Parkinson's disease	1.55e-05	0.000274	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.49e-05	0.000263	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—COMT—Parkinson's disease	1.4e-05	0.000247	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.39e-05	0.000246	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MAOA—Parkinson's disease	1.39e-05	0.000245	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.37e-05	0.000243	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—COMT—Parkinson's disease	1.32e-05	0.000233	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.31e-05	0.000232	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.31e-05	0.000231	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.3e-05	0.000229	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.28e-05	0.000226	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.24e-05	0.000219	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GPX1—Parkinson's disease	1.23e-05	0.000216	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.21e-05	0.000213	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.16e-05	0.000204	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.13e-05	0.0002	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.07e-05	0.000188	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—APOE—Parkinson's disease	1.05e-05	0.000186	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—APOE—Parkinson's disease	9.93e-06	0.000175	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—INS—Parkinson's disease	9e-06	0.000159	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—INS—Parkinson's disease	8.48e-06	0.00015	CbGpPWpGaD
